Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 21, 2020; 26(31): 4703-4717
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4703
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4703
Figure 3 Quantity of circulating mucosal-associated invariant T cells was associated with severity of hepatitis B virus-related liver failure.
A, B: The percentage (A) and number (B) of circulating mucosal-associated invariant T (MAIT) cells in early- (n = 28) and middle/late-stage (n = 27) hepatitis B virus (HBV)-related liver failure; C, D: Correlation between prothrombin activity (PTA) and percentage (C) or number (D) of circulating MAIT cells in patients with HBV-related liver failure. aP < 0.05, bP < 0.01. PBMC: Peripheral blood mononuclear cell. NS: No significance.
- Citation: Xue H, Li H, Ju LL, Han XD, Cheng TC, Luo X, Chen L, Shao JG, She YJ, Bian ZL. Mucosal-associated invariant T cells in hepatitis B virus-related liver failure. World J Gastroenterol 2020; 26(31): 4703-4717
- URL: https://www.wjgnet.com/1007-9327/full/v26/i31/4703.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i31.4703